Healthcare costs and obesity prevention: Drug costs and other sector-specific consequences

PharmacoEconomics

Volumn 27, Issue 12, 2009, Pages 1031-1044

  Rappange, David R ^a   Brouwer, Werner B F ^a   Hoogenveen, Rudolf T ^b   Van Baal, Pieter H M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; COST CONTROL; COST OF ILLNESS; DIABETES MELLITUS; DRUG COST; FEMALE; HEALTH CARE COST; HEART FAILURE; HOSPITAL CHARGE; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEOPLASM; OBESITY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROBABILITY; SMOKING;

COST-BENEFIT ANALYSIS; DRUG COSTS; HEALTH CARE COSTS; HEALTH CARE RATIONING; HEALTH EXPENDITURES; HEALTH RESOURCES; HUMANS; MARKOV CHAINS; MODELS, ECONOMETRIC; NETHERLANDS; OBESITY; QUALITY-ADJUSTED LIFE YEARS;

EID: 73549107872     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11319900-000000000-00000     Document Type: Article

References (63)

1. World Health Organization (WHO). Obesity: preventing and managing the global epidemic. Report of the WHO consultation of obesity. WHO Technical Report Series 894. Geneva: World Health Organization, 2000
2. Abelson PH, Kennedy D. The obesity epidemic [editorial]. Science 2004; 304: 1413
3. World Health Organization (WHO). Obesity and overweight. Factsheet N 311 [online]. Available from URL: http://www. who.int/mediacentre/factsheets/fs311/ en/index.html [Accessed 2008 Dec 12]
4. Kelly T, Yang W, Chen C-S, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32: 1431-1437
5. Visscher TLS, Seidell JC. The public health impact of obesity. Annu Rev Public Health 2001; 22: 355-375
6. Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197-1209
7. Hu FB. Obesity epidemiology. New York: Oxford University Press, 2008
8. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096
9. Neovius M, Sundstro J, Rasmussen F. Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study. BMJ 2009; 338: b496
10. Organization for Economic Cooperation and Development (OECD). Health at a glance. Paris: OECD, 2005
11. Allison DB, Zannolli R, Narayan V. The direct health care costs of obesity in the United States. Am J Public Health 1999; 89: 1194-1199
12. Thompson D, Edelsberg J, Colditz GA, et al. Lifetime health and economic consequences of obesity. Arch Intern Med 1999; 159: 2177-2183
13. van Baal PHM, Polder JJ, de Wit GA, et al. Lifetimemedical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med 2008; 5 (2): e29
14. Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003; 289: 187-193
15. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a lifetable analysis. Ann Intern Med 2003; 138: 24-32
16. Olshanksy SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352: 1138-1145
17. Barendregt JJ, Bonneux L, van derMaas PJ. The health care costs of smoking. N Engl J Med 1997; 337: 1052-1057
18. Sloan FAOJ, Picone G, Conover C, et al. The price of smoking. Cambridge (MA): MIT Press, 2004
19. Hoogenveen RT, Verkleij H, Jager JC. Investigation into the substitution of mortality and the impact of competing risks in case of quantitative health targets [in Dutch]. Bilthoven: National Institute for Public Health and the Environment (RIVM), 1990
20. Spilman BC, Lubitz J. The effect of longevity on spending for acute and long-term care. N Engl J Med 2000; 342: 1409-1415
21. Slobbe ICJ, Kommer GJ, Smit JM, et al. Cost of illness in the Netherlands [in Dutch]. Bilthoven: National Institute for Public Health and the Environment (RIVM), 2006
22. Ministry of Health, Welfare, and Sport (VWS). Health insurance in the Netherlands: the new health insurance system from 2006. The Hague: VWS, 2005
23. Van de VenWPMM, Schut FT. Universal mandatory health insurance in The Netherlands: a model for the United States? Health Aff 2008; 27: 771-781
24. Schut FT, van de Ven WPMM. Rationing and competition in the Dutch health-care system. Health Econ 2005; 14: S59-74
25. Council for Public Health and Health Care (RVZ). The labour market and demand for care [in Dutch]. TheHague: RVZ, 2006
26. Collins RW, Anderson JW. Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women. Prev Med 1995; 24: 369-374
27. Greenway FL, Ryan DH, Bray GA, et al. Pharmaceutical cost savings of treating obesity with weight loss medications. Obes Res 1999; 7: 523-531
28. Narbro K, Ågren G, Jonsson E, et al. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment. The SOS intervention study. Arch Intern Med 2002; 162: 2061-2069
29. Ågren G, Narbro K, Na?slund I, et al. Long-term effects of weight loss on pharmaceutical costs in obese subjects: a report from the SOS intervention study. Int J Obes 2002; 26: 184-192
30. Hoogenveen RT, van Baal PHM, Boshuizen HC. Chronic disease projections in heterogeneous aging populations: approximating multi-state models of joint distributions by modelling marginal distributions. Math Med Biol. Epub 2009 Jun 10
31. Van Baal PHM, Hoogenveen RT, de Wit GA, et al. Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity. Popul Health Metr 2006; 4: 14
32. Struijs JN, van Genugten ML, Evers SM, et al. Modeling the future burden of stroke in The Netherlands: impact of aging, smoking, and hypertension. Stroke 2005; 36: 1648-1655
33. Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, et al. Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study. Diabetes Care 2007; 30: 128-134
34. World Health Organization (WHO) expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163
35. National Institute for Public Health and the Environment. Cost of illness in the Netherlands [online]. Available from URL: http://www.costofillness.eu [Accessed 2009 Sep 8]
36. Meerding WJ, Bonneux L, Polder JJ, et al. Demographic and epidemiological determinants of health care costs in the Netherlands: cost of illness study. BMJ 1998; 317: 111-115
37. World Health Organization (WHO). International classification of diseases, injuries and causes of death, 9th revision. Geneva: WHO, 1977
38. Organization for Economic Cooperation and Development (OECD). A system of health accounts. Version 1.0. Paris: OECD, 2000
39. Health Care Insurance Board (CVZ).Guidelines for pharmacoeconomic research, updated version. Diemen: CVZ, 2006
40. Gold MR, Siegel JE, Russel LB, et al., editors. Costeffectiveness in health and medicine. Oxford: Oxford University Press, 1996
41. Smith DH, Gravelle H. The practice of discounting in economic evaluations of healthcare interventions. Int J Technol Assess Health Care 2001; 17: 236-243
42. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press Inc., 2005
43. Reuser M, Bonneux LG, Willekens FJ. The burden of mortality of obesity at middle and old age is small: a life table analysis of the US Health and Retirement Study. Eur J Epidemiol 2008; 23: 601-607
44. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293: 1861-1867
45. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA 1999; 282: 1530-1538
46. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA 2004; 291: 1238-1245
47. Mokdad AH, Marks JS, Stroup DF, et al. Correction: actual causes of death in the United States, 2000. JAMA 2005; 293: 293
48. Comas-Herrera A, Wittenberg R, Pickard L, et al. Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry 2007; 22: 1037-1045
49. Yang Z, Norton EC, Stearns SC. Longevity and health care expenditures: the real reasons older people spend more. J Gerontol B Psychol Sci Soc Sci 2003; 58 (1): S2-10
50. Van Baal PHM, van den BergM, Hoogenveen RT, et al. Costeffectiveness of a low-calorie diet and orlistat for obese persons: modelling long term health gains through prevention of obesity- related chronic diseases. Value Health 2008; 11: 1033-1040
51. BemelmansWJE, van Baal PHM,Wendel-VosWV, et al. The costs, effects and cost-effectiveness of counteracting overweight on a population level. Prev Med 2008; 46: 123-132
52. Van Baal PHM, Brouwer WBF, Hoogenveen RT, et al. Increasing tobacco taxes: a cheap tool to increase public health. Health Policy 2007; 28: 142-152
53. Van Baal PHM, Feenstra TL, Hoogenveen RT, et al. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect cost-utility ratio'. Health Econ 2007; 16: 421-433
54. Brouwer WBF, van Exel NJA, van Baal PHM, et al. Economics and public health: engaged to be happily married! Eur J Public Health 2007; 17: 122-123
55. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med 2006; 355: 920-927
56. Narbro K, Ågren G, Jonsson E, et al. Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord 1999; 23: 619-624
57. Vissher TLS, Rissanen A, Seidell JC, et al. Obesity and unhealthy life-years in adult Finns: an empirical approach. Arch Intern Med 2004; 164: 1413-1420
58. Sullivan PW, Ghushchyan V, Wyatt HR, et al. Productivity costs associated with cardiometabolic risk factor clusters in the United States. Value Health 2007; 10: 443-450 (Pubitemid 350013264)
59. Neovius M, Kark M, Rasmussen F, et al. Association between obesity status in young adulthood and disability pension. Int J Obes 2008; 32: 1319-1326
60. Meltzer D. Accounting for future costs in medical costeffectiveness analysis. J Health Econ 1997; 16: 33-64
61. Seidell JC. Epidemiology and health economics of obesity. Medicine 2006; 34: 506-509
62. Polder JJ, Takkern J, Meerding WJ, et al. Cost of illness in the Netherlands [in Dutch]. Bilthoven: National Institute for Public Health and the Environment (RIVM), 2002
63. Rappange DR, Brouwer WBF, Rutten FFH, et al. Lifestyle intervention: from cost savings to value for money. J Public Health. Epub 2009 Aug 7